2013•Annals of the Rheumatic DiseasesRequires access

FRI0008 Evidence for increased activity of interleukin-6 (IL-6) in seropositive rheumatoid arthritis (RA+), and differential tumour necrosis factor (TNF) receptor expression between ra+ and seronegative ra.

Martyna Skwarek, Babett Heschel, Julia Fantana, Martin Aringer

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Interleukin-6 receptor, Rheumatoid arthritis, Immunology, Peripheral blood mononuclear cell, Tumor necrosis factor alpha, Receptor, Antibody

Back to paper search Browse research topics Original source

FRI0008 Evidence for increased activity of interleukin-6 (IL-6) in seropositive rheumatoid arthritis (RA+), and differential tumour necrosis factor (TNF) receptor expression between ra+ and seronegative ra. — Research Paper | ScholarLens